Business
BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement of unsecured convertible debentures (the "Debentures") for aggregate gross proceeds of $335,670 (the "Offering").
About this update from Biovaxys Technology Corp
[{"type":"text","content":"// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // ","length":103,"tagName":"p"},{"type":"text","content":"VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement of unsecured convertible debentures (the "Debentures") for aggregate gross proceeds of $335,670 (the "Offering").","length":376,"tagName":"p"},{"type":"image","alt":"BioVaxys Technology Corp. (PRNewsfoto/BioVaxys Technology Corp.)","displaySize":"","headline":null,"caption":"BioVaxys Technology Corp. (PRNewsfoto/BioVaxys Technology Corp.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":63,"url":"https://media.zenfs.com/en/cnwgroup.com/cca0b1a397afc4499b82a11ef5413aff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9ulMxObQLWtbOLV3qJfMtQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/cca0b1a397afc4499b82a11ef5413aff","width":400,"height":63}},"href":"https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Debentures are unsecured obligations of the Company, mature August 30, 2026 (the "Maturity Date"), and bear interest at a rate of 10% per annum with such interest payable on a quarterly basis in either cash or, at the sole discretion of the Company, in common shares of the Company ("Shares"). The principal outstanding under the Debentures will be convertible into Shares at any time, at the option of the holder, at the closing price of the Shares on the Canadian Securities Exchange (the "CSE") on the day notice of conversion is received by the Company, subject to the pricing requirements in the policies of the CSE. If a holder elects to convert principal into Shares, all accrued and unpaid interest on the amount to be converted will also be satisfied with the issuance of Shares to such holder.","length":837,"tagName":"p"},{"type":"text","content":"Participants in the Offering also received, for every $1,000 of Debentures, 4,000 transferable common share purchase warrants ("Debenture Warrants") that, for each Debenture ...